Výsledky vyhledávání - "Joanna M. Hamilton"

Early Findings on the Use of Clinical Pathways for Management of Unwarranted Variation in Cancer Care

Autor: David M. Jackman, Carole Kathleen Tremonti, Joseph O. Jacobson, Emily Foster, Sherri O. Stuver, Joanna M. Hamilton, Craig A. Bunnell

Publikováno v: American Journal of Medical Quality. 37:103-110

Clinical pathways have the potential to improve complex clinical decision-making in cancer care. The authors implemented pathways with customized content to assist oncologists to select treatments, aiming for an on-pathway rate of 70%-85%. Treatment

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b22a81397a84ab9c50b54b62272f70f2
https://doi.org/10.1097/01.jmq.0000749852.10699.bc

Zobrazit plný text záznamu

Improving rates of venous thromboembolism prophylaxis in multiple myeloma patients on immunomodulatory drugs through a pharmacy-based system

Autor: Sydney Smith, Aric Parnes, Jacob P. Laubach, Nancy Berliner, Houry Leblebjian, Joanna M. Hamilton

Publikováno v: Journal of Oncology Pharmacy Practice. 28:421-424

Introduction Immunomodulatory drugs used to treat multiple myeloma carry an increased risk of venous thromboembolic (VTE) disease. Previously published guidelines outline consensus opinion on how to mitigate this risk. Methods We collected baseline d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba8443ae2324e9c3af83cc4b95935dcd
https://doi.org/10.1177/1078155221995885

Zobrazit plný text záznamu

Using clinical pathways to prospectively identify poor prognosis cancer patients: A preliminary analysis

Autor: Victoria H. Selesnick, Matthew Rice, Ariel Martin, Michael Scalzo, Joseph O. Jacobson, David M. Jackman, Joanna M. Hamilton, Abhijit Sanyal, James A. Tulsky, Jocelyn Siegel

Publikováno v: Journal of Clinical Oncology. 39:329-329

329 Background: Cancer patients in the last year of life may have different clinical needs and evolving goals of care. Helping clinicians consistently identify such patients in a systematic and prospective fashion, at a discrete moment in the care tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::84ab6fd9a422d0e5df08e8bd38af0b93
https://doi.org/10.1200/jco.2020.39.28_suppl.329

Zobrazit plný text záznamu

Understanding practice variation with a clinical pathways system: Differences by physician and practice factors, and changes in practice over time

Autor: Emily Foster, Carole Kathleen Tremonti, David M. Jackman, Joseph O. Jacobson, Craig A. Bunnell, Sherri O. Stuver, Joanna M. Hamilton

Publikováno v: Journal of Clinical Oncology. 38:2079-2079

2079 Background: Clinical oncology pathways aim to support clinical decision-making and reduce unwarranted practice variation across an enterprise. The Dana-Farber Cancer Institute (DFCI) implemented web-based oncology pathways with DFCI-customized c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbb5b9eb7da92fc0528e737086b9997a
https://doi.org/10.1200/jco.2020.38.15_suppl.2079

Zobrazit plný text záznamu

Temporal and spatial variability of trace volatile organic compounds in rainwater

Autor: Ralph N. Mead, Joanna M. Hamilton, Joan D. Willey, Katherine M. Mullaugh, G. Brooks Avery, Robert J. Kieber, J. David Felix

Publikováno v: Chemosphere. 134:203-209

This study presents the first detailed concentration profile of trace VOCs in atmospheric waters. Analytes were detected and quantified in 111 unique rain events in Wilmington, NC, USA over a one-year period. Headspace solid phase microextraction was

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6acb2e2afbb7344fa6ed95000054fe8a
https://doi.org/10.1016/j.chemosphere.2015.04.027

Zobrazit plný text záznamu

Everyone needs robust analytics: Integrating medical ontologies into the Dana-Farber Pathways

Autor: Joanna M. Hamilton, David M. Jackman, Carole Kathleen Tremonti, Debra McNeil, Joseph O. Jacobson, Dana Milne, John Methot

Publikováno v: Journal of Clinical Oncology. 37:304-304

304 Background: The majority of clinical data is unstructured. Medical ontologies standardize the language used to communicate diagnoses, symptoms, and procedures used in healthcare. Incorporating medical ontologies into the Dana-Farber Pathways (DFP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3067a15d7af56dce9e1a2c4b63ebcca9
https://doi.org/10.1200/jco.2019.37.27_suppl.304

Zobrazit plný text záznamu

Maintaining clinical pathways: What does it really take?

Autor: Emily E. Meserve, Matthew Wolfson, Victoria Hayne, Laura Holtz, Joanna M. Hamilton, David M. Jackman, Houry Leblebjian, Carole Kathleen Tremonti, Joseph O. Jacobson, Debra McNeil, Dana Milne

Publikováno v: Journal of Clinical Oncology. 37:305-305

305 Background: Building pathways to support clinical decision making is one step, maintaining them is a mountain. Dana-Farber Cancer Institute has built 34 medical oncology (MO) pathways (PWs) and 27 radiation oncology (RO) PWs. These PWs are manage

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::afb841c976509598d03f203804f4aa6d
https://doi.org/10.1200/jco.2019.37.27_suppl.305

Zobrazit plný text záznamu

Structuring clinical pathways: Creating common language where there is none

Autor: Debra McNeil, David M. Jackman, John Methot, Laura Holtz, Houry Leblebjian, Joseph O. Jacobson, Carole Kathleen Tremonti, Joanna M. Hamilton, Matthew Wolfson, Dana Milne, Victoria Hayne, Emily E. Meserve

Publikováno v: Journal of Clinical Oncology. 37:303-303

303 Background: Clinical pathways (PW) consist of Decision Criteria (DC) such as patient and disease characteristics, prior therapy, and genetic tests. Historical Dana-Farber Pathways (DFP) content was unstructured and maintained in static documents.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67376d6b63e47e543c713a49bec8c658
https://doi.org/10.1200/jco.2019.37.27_suppl.303

Zobrazit plný text záznamu

Metal Ion Complexing Properties of Dipyridoacridine, a Highly Preorganized Tridentate Homologue of 1,10-Phenanthroline

Autor: Joanna M. Hamilton, Robert D. Hancock, Neil J. Williams, Maya El Ojaimi, Jason R. Whitehead, Randolph P. Thummel

Publikováno v: Inorganic Chemistry. 50:3785-3790

DPA (dipyrido[4,3-b;5,6-b]acridine) may be considered as a tridentate homologue of phen (1,10-phenanthroline). In this paper some of the metal ion complexing properties of DPA in aqueous solution are reported. Using UV-visible spectroscopy to follow

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae33da42c8f8d0c7f44db34943e11ba1
https://doi.org/10.1021/ic200184c

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání